London Stock Exchange Notice Cancellation - Dechra Pharmaceuticals Plc (8867Z)
January 17 2024 - 3:00AM
UK Regulatory
TIDMDPH
RNS Number : 8867Z
London Stock Exchange Notice
17 January 2024
NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON THE LONDON
STOCK EXCHANGE
17/01/2024 - 08:00
At the request of the company the following securities have been
cancelled from admission to trading on London Stock Exchange with
effect from the time and date of this notice.
DECHRA PHARMACEUTICALS PLC
213800J4UVB5OWG8VX82
ORDINARY SHARES (0963318)(GB0009633180) DECA PHAR/PAR VTG FPD 0.01
OF 1P EACH FULLY
PAID
----------------------- --------------------------
If you have any queries relating to the above, please contact
Market Operations at the London Stock Exchange on 020 7797
4310.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
SENGPUPAGUPCGWQ
(END) Dow Jones Newswires
January 17, 2024 03:00 ET (08:00 GMT)
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Oct 2024 to Nov 2024
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Nov 2023 to Nov 2024